News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Male reproductive health problems could begin in the womb
Disruptions to male babies’ development early during pregnancy could have a profound effect on a man’s future reproductive health, according to new research.… Read more
-
Two bros, no lab, but a laptop and a microphone
Ben Amberg and Mikee Inocencio are, in their own words, “two bros who met while doing PhDs”.
When COVID-19 hit, the friends found themselves, like many of us, in a whole new world in lockdown without their daily banter.… Read more -
Weighing up home birth vs hospital in the wake of coronavirus
There’s been a reported surge in women seeking home births since the outbreak of coronavirus in Australia.
Research led by Hudson Institute has shown home birth is safe for women with low-risk pregnancies.… Read more -
US FDA approval sought for clinical trial – potential COVID-19 treatment
Biotech company Noxopharm is seeking approval from the US FDA for a clinical trial in COVID-19 patients of an end-stage prostate cancer drug, following a discovery by Hudson Institute researchers that it could act as an anti-inflammatory.… Read more
-
Our response to COVID-19
Hudson Institute has responded to the coronavirus outbreak (COVID-19) both scientifically and to protect the wellbeing of our staff and community. Our world-leading scientists are applying their expertise in hyper-inflammation, to find ways to reduce the body’s overwhelming inflammatory response and acute respiratory distress that is leading to loss of lives from COVID-19. During this… Read more
-
Cancer drug investigated as anti-inflammatory for lethal conditions including COVID-19
An existing cancer drug could potentially modify a severe hyper-inflammatory ‘storm’ associated with some conditions, which may include the COVID-19 virus, according to Hudson Institute researchers.… Read more
-
Keeping stomach cancer at bay
Researchers have identified a protein in immune cells that may play a role in thwarting a type of stomach cancer, paving the way for possible prevention therapies.… Read more
-
Simple blood test can improve ovarian cancer diagnosis
Researchers have developed a simple blood test that measures the body’s own immune response to improve diagnosis of ovarian cancer.… Read more
-
Gut bacteria and the immune system—mapping out interactions
Hudson Institute scientists Dr Emily Gulliver and Dr Sam Forster were part of a leading collaborative study with the Wellcome Sanger Institute, which created the first detailed cell atlas of immune cells and gut bacteria within the human colon.… Read more
-
Unearthing a new form of toxic inflammation
Hudson Institute scientists have discovered how a molecule is transferred between damaged cells and healthy immune cells, which might cause toxic inflammation in a host of diseases.… Read more
Hudson News
Get the inside view on discoveries and patient stories